相关实验视频
Updated: Jul 28, 2025

09:15
In Vitro Thrombosis Test for Ventricular Assist Devices
Published on: March 21, 2025
722
静脉注射的Hydroxocobalamin在血管的耐用性
Madeline Blaha1, Meghan Blais1, Logan Olson1
1Department of Pharmacy, Nebraska Medicine, Omaha, USA.
Cureus
|May 31, 2023
概括
静脉注射的可巴胺 (B12) 在31%的耐火分发性休克患者中快速降低了血管压缩剂的需求. 血液动力学改善持续时间中位数为210分钟,提供了潜在的治疗选择.
科学领域:
- 关键护理医学 关键护理医学
- 药理学 药理学是指药理学的学科.
- 紧急医疗 紧急医疗
背景情况:
- 阻断性分布性休克,以血管为特征,是一个重大的临床挑战.
- 静脉注射可巴胺 (B12) 已成为一种潜在的治疗方法,但其疗效和效果持续时间需要进一步描述.
研究的目的:
- 在耐火分布性休克患者静脉注射可巴胺后,量化血液动力学改善的持续时间.
- 为了确定与对氧巴胺治疗的反应相关的患者特征.
主要方法:
- 回顾成人重症监护病房患者的回顾性图表审查,这些患者在血管压缩剂时接受静脉注射可巴胺.
- 患者被分为响应者 (60分钟内血管压缩剂需求下降≥10%) 和不响应者.
- 分析了血液动力学参数,特别是上腺素等效 (NEE) 率.
主要成果:
- 31% (5/16) 的患者符合应答者标准,平均应答时间为15分钟.
- 响应者的血液动力学改善维持了平均210分钟.
- 基线NEE率在响应者 (32.9微克/分钟) 与未响应者 (24.7微克/分钟) 相比较高.
结论:
- 静脉注射氧巴胺导致阻断性分布性休克患者的一个子组的血管压缩剂需求迅速和持续下降.
- 氧巴胺显示出作为治疗血管的治疗剂的潜力.
- 需要进一步的前性研究来证实这些发现并优化治疗方案.
关键词:
b12b12b12b12b12b12b12b12b12b12bb12bb12bb12bbbb12bbbb12bbb12bbbbbb12bbbbbb12bb12bbb12bbbb12bbbbb12bbbbbb12bbbbb12bbbbbbb12bbbbb12bbbb12bbb12bbbbb12bbbb12bbbbbbb12bbbbb12bbbb12bbbbbbb12bbbbb12bbbb12bbbb12bbb12bb12bb12bbb12bbbb12bbbb12bbbbb12bbb12bbbbbb12bbbb12bbbb12b12bb12bbb12bbbb12bbb12bbbb12bbb12b12bb12bbb12bbbb12bb12bbb12b分布式冲击是一种分布式冲击.血液动力学 血液动力学氧巴胺是一种氧.血管的病例包括血管相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
773
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
773
Hemodialysis II: Procedure and Complications
43
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
43
Venous Thrombosis III: Interprofessional Care
12
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
12
Hemodialysis I: Introduction
72
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
72
Nonlinear Pharmacokinetics: Drug Elimination for IV Bolus Injection
106
In pharmacokinetics, the elimination rate of a drug following a capacity-limited model is primarily controlled by two parameters: Vmax and KM. These parameters are crucial in how the drug behaves inside the body after administration.
Following the administration of a single intravenous (IV) bolus injection, we can determine the concentration of the drug in the plasma at any given time. This calculation is achieved using a specific equation that integrates the values of Vmax and KM.
We can also...
Following the administration of a single intravenous (IV) bolus injection, we can determine the concentration of the drug in the plasma at any given time. This calculation is achieved using a specific equation that integrates the values of Vmax and KM.
We can also...
106
Acute Kidney Injury IV: Diagnostic Studies and Prevention
41
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
41

